Skip to main content

GeraClinic / NHS cancer waiting times / NHS Birmingham And Solihull ICB

NHS Birmingham And Solihull ICB: NHS Cancer Waiting Times

In April 2026, 65.1% of cancer patients in NHS Birmingham And Solihull ICB started treatment within 62 days of urgent referral — 4.7 percentage points below the England average. Gera Cancer Pathway Pressure Index: 26.3/100 (below-average pathway pressure). Official NHS England data.

Reference period: April 2026(NHS England Cancer Waiting Times, published June 2026) · updated monthly · Open Government Licence v3.0 · England

What is the NHS cancer waiting time in NHS Birmingham And Solihull ICB?

As of April 2026, 65.1% of cancer patients in NHS Birmingham And Solihull ICB started treatment within 62 days of urgent referral — 4.7 percentage points below the England average (NHS target: 85%) — covering 542 patients, per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.

Source:NHS England Cancer Waiting Times (CWT CRS) — ICB Sub-Location extract·as of April 2026updated monthly (last: )
Gera Cancer Pathway Pressure Index26.3 / 100NHS Birmingham And Solihull ICB — below-average pathway pressureHow this index is calculated

The GCPPI for NHS Birmingham And Solihull ICB = (1 − 65.1% / 100) × 4,862 FDS referrals = raw pressure 1697, normalised to 26.3/100. Rank 21 of 36 ICBs (rank 1 = most pressure). See methodology.

NHS cancer waiting times figures for NHS Birmingham And Solihull ICB (April 2026)
MeasureNHS Birmingham And Solihull ICBWhat it means
62-day standard met65.1%NHS target: 85%
28-day FDS met82.1%NHS target: 75%
Patients in 62-day pathway542All four 62-day sub-pathways
FDS referral volume4,862Faster Diagnosis Standard demand
Gera Pressure Index (GCPPI)26.3 / 100below-average pathway pressure
Pathway pressure rank21 / 36Rank 1 = most pressure in England
62-day pathway breakdown for NHS Birmingham And Solihull ICB (April 2026)
PathwayPatients62-day metStandard
Urgent Suspected Cancer28555.1%Missed
Screening2864.3%Missed
Consultant Upgrade22778.0%Missed
Breast Symptomatic250.0%Missed

Check your area's cancer pathway pressure

Compare NHS Birmingham And Solihull ICB with other ICBs — real NHS data, updated monthly

In NHS Birmingham And Solihull ICB, 65.1% of cancer patients started treatment within 62 days of urgent referral in April 2026 — 4.7 percentage points below the England average. The NHS standard is 85%.

62-day standard met

65.1%

NHS target: 85%

28-day FDS met

82.1%

Faster Diagnosis Standard (75%)

Gera Pressure Index

26.3 / 100

below-average pathway pressure

542 patients reached a 62-day treatment decision in this ICB (April 2026); England total: 27,522.

Pathway breakdown (62-day, April 2026):

PathwayPatientsMet standard
Urgent Suspected Cancer28555.1%
Screening2864.3%
Consultant Upgrade22778.0%
Breast Symptomatic250.0%

NHS Birmingham And Solihull ICB is at 65.1% on the 62-day standard — below the NHS 85% target. GeraClinic can connect you to a cancer specialist quickly while you await NHS assessment.

Book a cancer consultation

Compare cancer waiting times in other areas

Sorted by Gera Cancer Pathway Pressure Index (highest pressure first).

NHS Birmingham And Solihull ICB cancer waiting times: FAQs

What is the NHS cancer 62-day waiting time in NHS Birmingham And Solihull ICB?
In April 2026, 65.1% of cancer patients in NHS Birmingham And Solihull ICB started treatment within 62 days of urgent referral — 4.7 percentage points below the England average. The NHS target is 85%. Data: NHS England Cancer Waiting Times.
What is the Gera Cancer Pathway Pressure Index for NHS Birmingham And Solihull ICB?
The Gera Cancer Pathway Pressure Index (GCPPI) for NHS Birmingham And Solihull ICB in April 2026 is 26.3/100 (below-average pathway pressure). It is computed as (1 − 62-day standard met rate) × referral volume, normalised across all 36 ICBs. NHS Birmingham And Solihull ICB ranks 21 of 36 ICBs by pathway pressure.
How does NHS Birmingham And Solihull ICB compare on the 28-day Faster Diagnosis Standard?
In April 2026, 82.1% of patients in NHS Birmingham And Solihull ICB received a cancer diagnosis or ruling-out within 28 days (NHS FDS target: 75%). NHS Birmingham And Solihull ICB processed 4,862 FDS referrals in this period, per NHS England Cancer Waiting Times data.
Can I be seen privately while waiting for cancer assessment in NHS Birmingham And Solihull ICB?
Yes. Being assessed or treated privately does not affect your NHS referral. GeraClinic can connect you to a UK-registered cancer specialist. You keep your place on the NHS list and can access a private consultation simultaneously.
What are the main cancer pathways in NHS Birmingham And Solihull ICB?
The NHS 62-day standard in NHS Birmingham And Solihull ICB covers four pathways: Urgent Suspected Cancer (the primary 2-week-wait route), Screening (referrals from NHS screening programmes), Consultant Upgrade (reclassification onto the 62-day pathway by a clinician), and Breast Symptomatic (non-2WW breast referrals). In April 2026, NHS Birmingham And Solihull ICB recorded 542 patients across all four pathways.

NHS Birmingham And Solihull ICB is below the NHS 85% cancer target

Only 65.1% of cancer patients in NHS Birmingham And Solihull ICB met the 62-day standard in April 2026 (NHS target: 85%). GeraClinic can connect you to a UK-registered cancer specialist quickly — you keep your NHS referral while getting faster private assessment.

Data and methodology

Figures for NHS Birmingham And Solihull ICB are aggregated from the real per-sub-location count rows in NHS England's April 2026 Cancer Waiting Times ICB Sub-Location extract. Each sub-location code (e.g. multiple [ICB sub-location codes, NHS ODS]) is mapped to its parent ICB via the NHS Organisation Data Service and summed for both the 62-day Combined and 28-day FDS standards. Percentages are re-derived from summed numerators and denominators — not averaged. The Gera Cancer Pathway Pressure Index = (1 − 62-day met rate) × referral volume, normalised 0–100. No estimates or invented numbers. See full methodology.

Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0.